Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Elevated circulating aspartate aminotransferase concentration, Nephritis, Elevated platelet count (thrombocytosis), and Increased circulating interleukin 6 concentration and others. 23 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 6 | Elevated circulating aspartate aminotransferase concentration, Increased circulating interleukin 6 concentration, Elevated ferritin (iron storage marker) (increased circulating ferritin concentration) |
HMOX1 encodes heme oxygenase 1 (288 aa). Catalyzes the oxidative cleavage of heme at the alpha-methene bridge carbon, released as carbon monoxide (CO), to generate biliverdin IXalpha, while releasing the central heme iron chelate as ferrous iron. Highest expression in Spleen (895.4 TPM) and Cells Cultured fibroblasts (185.9 TPM).
Heme oxygenase 1 deficiency is strongly associated with mutations in the HMOX1 gene on chromosome 22.
The HMOX1 protein participates in Cellular response to chemical stress pathway.
HMOX1 is classified as a druggable target (Drug Resistance, Druggable Genome, and Enzyme categories) with score 5.8.
Genetic testing for HMOX1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 22 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for heme oxygenase 1 deficiency.
6 publications have been identified in PubMed for heme oxygenase 1 deficiency. Research spans Basic Science / Preclinical (100%).
Alves de Souza RW (2026). [PMID: 42136106](https://pubmed.ncbi.nlm.nih.gov/42136106/). *J Cachexia Sarcopenia Muscle*. [Basic Science / Preclinical]
Rana M (2025). [PMID: 41015105](https://pubmed.ncbi.nlm.nih.gov/41015105/). *Dev Biol*. [Basic Science / Preclinical]
Chen G (2025). [PMID: 40001185](https://pubmed.ncbi.nlm.nih.gov/40001185/). *Stem Cell Res Ther*. [Basic Science / Preclinical]
Berendes LS (2025). [PMID: 40945734](https://pubmed.ncbi.nlm.nih.gov/40945734/). *J Biol Chem*. [Basic Science / Preclinical]
Patel AK (2024). [PMID: 39348688](https://pubmed.ncbi.nlm.nih.gov/39348688/). *Blood Adv*. [Basic Science / Preclinical]
Chudy P (2024). [PMID: 39047636](https://pubmed.ncbi.nlm.nih.gov/39047636/). *Redox Biol*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 18, 2026, 3:43 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Kidneys and urinary system | 3 | Nephritis, Blood in the urine (hematuria), Protein in the urine (proteinuria) |
Blood and immune system | 3 | Elevated platelet count (thrombocytosis), Red blood cell destruction (hemolytic anemia), Coombs-positive hemolytic anemia |
Brain and nerves | 1 | Global developmental delay |
Digestive system | 1 | Enlarged liver (hepatomegaly) |
Heart and blood vessels | 1 | Hypertension |
Growth and development | 1 | Growth delay |
Age of onset: childhood.